S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
S&P 500   4,076.57
DOW   34,395.01
QQQ   293.72
Is Apple Going To Rally Into Year End?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
25 Ways to Improve Your Financial Situation in 1 Hour
Are the Short Sellers Still Right About Mullen Automotive stock? 
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
La-Z-Boy Reclines To More Comfortable Levels 
Is The Recovery Rally Here For SoFi?
Market Wizard who made $95 million for his clients in 2008 – and predicted the 2022 collapse (Ad)
Biden administration presses senators to avert rail strike
Trump Org. defense lawyer scolded for using struck testimony
OTCMKTS:KNWN

Know Labs - KNWN Stock Forecast, Price & News

$2.53
-0.09 (-3.44%)
(As of 09/15/2022)
Add
Compare
Today's Range
$2.45
▼
$2.75
50-Day Range
$2.53
▼
$2.53
52-Week Range
$1.15
▼
$4.00
Volume
481,300 shs
Average Volume
60,338 shs
Market Capitalization
$110.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Know Labs MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
176.7% Upside
$7.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.13mentions of Know Labs in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.26) to ($0.11) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.79 out of 5 stars

See Top Rated MarketRank™ Stocks Here
KNWN stock logo

About Know Labs (OTCMKTS:KNWN) Stock

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Receive KNWN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter.

KNWN Stock News Headlines

November 28, 2022 | msn.com
Drydock turned lab space: Inside developer Jon Cronin’s plans for a unique corner of Boston’s waterfront
November 28, 2022 | msn.com
Jon Cronin has a plan for improving the city’s last working drydock: Lab space.
November 27, 2022 | msn.com
Idaho state crime lab prioritizes evidence testing in college students' brutal murder case
November 24, 2022 | msn.com
National Dog Show: What to know about the Thanksgiving TV contest and its 2022 newbies
November 18, 2022 | msn.com
Much-debated labs in Leather District and Fort Point win BPDA approval
November 18, 2022 | msn.com
UCSF study: Molecule can reverse effects of concussions in lab mice
November 16, 2022 | msn.com
Matter Labs, the company behind zkSync, raises $200 million to scale Ethereum
November 10, 2022 | msn.com
Rocket Lab will launch its 1st mission from US soil on Dec. 7
November 8, 2022 | thestreet.com
Meta Layoff Reports: Everything We Know So Far
November 7, 2022 | forbes.com
New Questions About The Origin Of Covid-19: Lab Leak Or Not?
November 7, 2022 | msn.com
Blood on tap? Lab-grown blood transfused to people in world-first clinical trial
November 4, 2022 | msn.com
NBA Top Shot maker Dapper Labs lays off 22% of workers
November 4, 2022 | msn.com
Russia Envoy Sees 'Inconvenient Truth' Behind Bio Labs U.S. Says Save Lives
November 4, 2022 | msn.com
Watch Rocket Lab launch satellite, catch booster with a helicopter Friday
November 1, 2022 | msn.com
A Look Inside Pepsi Music Lab’s Partnership With UnitedMasters: Exclusive
November 1, 2022 | msn.com
From Hunter Biden to the Wuhan lab-leak theory, eight times the media admitted it got a major narrative wrong
October 29, 2022 | markets.businessinsider.com
EQS-News: Can Big Data Make Patient Care More Personalized And Effective?
October 27, 2022 | msn.com
Does Zuckerberg Know Secret Of the Metaverse That Eludes Us?
October 27, 2022 | msn.com
A New Lab-Made COVID-19 Virus Puts Gain-of-Function Research Under the Microscope
October 25, 2022 | msn.com
An earthquake just shook the Bay Area. Here's what to know about the obscure Calaveras Fault.
October 25, 2022 | forbes.com
An Enabling Technology For Lab-Grown Meat
October 24, 2022 | msn.com
What to know about R.I.’s $165m health lab project
October 17, 2022 | msn.com
What to Know About Wayfair's Second Way Day 2022 Sale
October 15, 2022 | techcrunch.com
Uniswap Labs valued at $1.66 billion in $165 million new funding
October 13, 2022 | msn.com
Yuga Labs part of SEC probe into broader NFT market
See More Headlines
Receive KNWN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter.

KNWN Company Calendar

Last Earnings
8/07/2019
Today
12/02/2022
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Measuring & Controlling Devices
Sub-Industry
N/A
Sector
Business Services
Current Symbol
OTCMKTS:KNWN
CUSIP
N/A
CIK
1074828
Web
www.knowlabs.co
Phone
(206) 903-1351
Fax
206-826-0451
Employees
12
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$7.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+176.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.60)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-25,360,000.00
Net Margins
N/A
Pretax Margin
-506.81%
Return on Equity
-907.68%
Return on Assets
-176.55%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.82
Quick Ratio
1.82

Sales & Book Value

Annual Sales
$120,000.00
Price / Sales
924.90
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.04 per share
Price / Book
63.25

Miscellaneous

Outstanding Shares
43,869,000
Free Float
37,113,000
Market Cap
$110.99 million
Optionable
Not Optionable
Beta
2.40

Key Executives

  • Mr. Ronald P. Erickson J.D. (Age 78)
    Founder, Chairman & Treasurer
    Comp: $366.04k
  • Mr. Phillip A. Bosua (Age 48)
    CEO & Director
    Comp: $663.76k
  • Mr. Peter Joseph Conley
    CFO & Sr. VP of Intellectual Property
  • Mr. Leonardo Troutwein
    Chief Marketing Officer
  • Dr. James H. Anderson Jr.
    M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board
  • Mr. Steven T. Kent
    Chief Product Officer
  • Mr. Masanori Takee
    Sr. VP of Software Engineering

Key Competitors

View All Competitors













KNWN Stock - Frequently Asked Questions

Should I buy or sell Know Labs stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Know Labs in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" KNWN shares.
View KNWN analyst ratings or view top-rated stocks.

What is Know Labs' stock price forecast for 2023?

1 equities research analysts have issued twelve-month target prices for Know Labs' stock. Their KNWN share price forecasts range from $7.00 to $7.00. On average, they anticipate the company's share price to reach $7.00 in the next year. This suggests a possible upside of 176.7% from the stock's current price.
View analysts price targets for KNWN or view top-rated stocks among Wall Street analysts.

How have KNWN shares performed in 2022?

Know Labs' stock was trading at $1.6975 at the start of the year. Since then, KNWN shares have increased by 49.0% and is now trading at $2.53.
View the best growth stocks for 2022 here.

How were Know Labs' earnings last quarter?

Know Labs, Inc. (OTCMKTS:KNWN) issued its quarterly earnings data on Wednesday, August, 7th. The company reported ($0.04) EPS for the quarter. The company had revenue of $0.38 million for the quarter.

What other stocks do shareholders of Know Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Know Labs investors own include Denali Therapeutics (DNLI), Co-Diagnostics (CODX), Onconova Therapeutics (ONTX), Sierra Oncology (SRRA), Acura Pharmaceuticals (ACUR), Actinium Pharmaceuticals (ATNM), AzurRx BioPharma (AZRX), CytoDyn (CYDY), (GBSN) (GBSN) and Home Depot (HD).

What is Know Labs' stock symbol?

Know Labs trades on the OTCMKTS under the ticker symbol "KNWN."

How do I buy shares of Know Labs?

Shares of KNWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Know Labs' stock price today?

One share of KNWN stock can currently be purchased for approximately $2.53.

How much money does Know Labs make?

Know Labs (OTCMKTS:KNWN) has a market capitalization of $110.99 million and generates $120,000.00 in revenue each year. The company earns $-25,360,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

How can I contact Know Labs?

Know Labs' mailing address is 500 UNION STREET SUITE 810, SEATTLE WA, 98101. The official website for the company is www.knowlabs.co. The company can be reached via phone at (206) 903-1351, via email at vsul@liolios.com, or via fax at 206-826-0451.

This page (OTCMKTS:KNWN) was last updated on 12/2/2022 by MarketBeat.com Staff